Article Details
Retrieved on: 2018-07-03 05:38:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>As of May 31, 2018 neither the Firm nor its affiliates beneficially own 1% or more of any class of common <b>equity securities</b> of Adamis Pharmaceuticals ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here